Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 174.45 2.56
Cipla Lt 557.40 8.38
Ong Corp 444.60 2.17
Tata Stl 519.20 1.10
Ntpc Ltd 140.10 1.74
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Arch Pharmalabs Limited
Arch Pharmalabs Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:24729NSE:NABloomberg:MRVDP@INReuters:MERV.BO
Market Lot: Face Value: 10ISIN Demat: INE182F01017
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
11-JUN-12 Credit rating agency, ICRA has reaffirmed the A rating on the Rs 1.5 billion, Non Convertible Debenture (NCD) programme of Arch Pharmalabs (APL). ICRA has also assigned an A rating to the Rs 1.5 billion additional NCD programme of APL. 07-OCT-10 Credit rating agency, ICRA has reaffirmed the short-term rating of A1 on the commercial paper/ short term debt programme of Arch Pharmalabs (APL) for Rs 1.5 billion (enhanced from Rs 1 billi...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
ICRA assigns `IPO Grade 4` to Arch Pharmalabs  -IRIS 29-Nov-11
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2007 (12)31-Mar-2006 (12)31-Mar-2005 (12)
Net sales 3625.522468.271555.03
Other Income11.171.362.52
Total Income3636.692469.631557.55
Cost of goods sold2930.252004.161272.37
OPBDIT706.44465.47285.18
PAT301.65159.13102.33
Gross Block2081.801395.17892.29
Equity capital160.87136.87131.71
EPS (Rs.)18.7511.637.48
DPS (Rs.)0.000.000.00
BV (Rs.)105.6759.3946.00
P/E range (x)NANANA
Debt / Equity (x)1.752.301.77
Operating margin (% of OI)19.418.818.3
Net margin (% of OI) 8.3 6.4 6.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
4th Floor, H Wing, Tex Centre
Off Saki Vihar Road
Chandivali
Andheri (East)
Mumbai
Maharashtra-400 072
PHONE
(022) 2847 0555-64
FAX
(022) 2847 1234/ 1002
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer